arrow
S

Sara Caamiña

hospital universitario nuestra senora de candelaria
H指数:5
被引数:114

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prediction of preterm pre-eclampsia and preterm small-for-gestational-age at 24–28 weeks of gestation using ultrasound and biochemical markers in high-risk pregnancies treated with aspirin: A secondary analysis of the StopPRE trial

使用超声和生物化学标志物预测接受阿司匹林治疗的高危妊娠在24~28周时的早产子痫前期和早产胎儿宫内生长受限:StopPRE试验的二次分析

2026-09-300
PRE
Placental growth factor at 24-28 weeks for aspirin discontinuation in pregnancies at high risk for preterm preeclampsia: Post hoc analysis of StopPRE trial
2024-08-222
OAAI
Clinical effectiveness of routine first-trimester combined screening for pre-eclampsia in Spain with the addition of placental growth factor
2023-10-092
OA
Aspirin Discontinuation at 24 to 28 Weeks' Gestation in Pregnancies at High Risk of Preterm Preeclampsia: A Randomized Clinical Trial Comment
2023-08-010
PRE
Aspirin Discontinuation at 24 to 28 Weeks' Gestation in Pregnancies at High Risk of Preterm Preeclampsia A Randomized Clinical Trial
2023-02-2124
OA